Erik De Vries Email & Phone Number

Zwingenberg, Hessen, De

Enzymes play a key role in the circular economy and for a bioeconomy. We see it as a challenge and a task to take proven evolutionary developments as a starting point and make them usable for industrial purposes.At BRAIN, we identify and develop optimized enzymes and biocatalysts that meet complex process and application requirements. These include enzymes for the production of food and beverages, wound care preparations or lubricants as well as enzymes for the production of starch and bioethanol.We are now exploring projects in the pharmaceutical industry as it becomes more and more important to support small molecule API and therapeutic protein/enzyme development with good enzymes and strains that enable robust manufacturing.

Singapore, Singapore, Sg

Providing technical guidance on anything related to biocatalysis, writing of proposals for projects and grants, and generally supporting the company's growth scenario.

Singapore, Singapore, Sg

Allozymes is a start up company that has recently come out of stealth mode. They have developed proprietary microfluidic chip technology to allow screening of biocatalytic conversions on the individual cell level in a microdroplet (whole cells, or lysed cells). Much like FACS, but then orders of magnitude better! With applications in directed evolution and strain engineering, saving time and consumables, this hardware/service company is leading the way to ultra fast enzyme engineering.My consulting support includes determining the value proposition, corporate strategy and general business support.

London, England, Gb

FabricNano is a biotechnology company based in London. Our mission is to transform industrial chemical processes using cell-free biomanufacturing. Empowering users with the world’s most advanced, flexible and easily-scalable biocatalyst platform.We develop and sell biocatalysts for high volume industrial applications. Data-driven in our approach to enzyme and Immobilization Engineering™, we only use biocatalyst materials that can already be manufactured by the tonne.Our clients range from startups to international chemical clients like Sumitomo Chemical Company, all of which are looking for highly stable and performant biocatalysts to enable profitable production of sustainable and bio-based chemicals.The FabricNano offer starts with novel Immobilization Engineering™ for enzyme stabilization, followed by budget-conscious protein engineering and process engineering to reach the client’s targets for commercialization of the new biochemical production process.As of February 2022, I am member of the Scientific Advisory Board.

In 2019, I started my consulting company Industrial Biotechnology Consulting. Main focus is on supporting start-ups and small to medium-sized companies navigate the world of biotechnology, biocatalysis, bio-based materials.Activities include:-Business Development Support-Marketing and Communications-Regulatory aspects in different industries-Project ManagementExperience in Pharmaceuticals, Renewable Chemicals, Cosmetic Ingredients. The past few years, I have successfully particpated in the drafting of research proposals for 3 EU funded programs (totalling 2 million euros for my clients, one for Enzymicals AG, two for Mellizyme Biotechnology) and one German BMBF grant (passed first stage, writing full proposal now - Jan 2022). These projects are all in the field of enzymatic degradation of plastic waste.Send me a message to discuss your needs!!

Greifswald , Mv, De

As of March 2022, I am heading up Enzymicals AG as CEO. The company is located in the wonderful town of Greifswald, Germany but I will be working mainly from my home in The Netherlands.

Greifswald , Mv, De

I am managing all administration for Enzymicals for this 4-year long Horizon 2020 EU project on enzymatic polymer degradation.Enzymicals is a leader in one key work package (WP) on developing biocatalytic degradation of plastic wastes and upcycling of the product stream to new biopolymers and/or bio-based fine chemicals. Enzymicals contributes biocatalysis and protein manufacturing expertise to several other WPs.In this project, I am the Technical Manager of the entire project and as such, I am member of the upPE-T Executive Board and the upPE-T Innovation Board.

London, Gb

Supporting the formulation of a business case and writing parts of the business plan in the early stages of the company's development.Consultation on general business strategy and networking is ongoing.Managing and coordinating activities for EU funded projects Agro2Circular and REPurpose (to start May 2022), both projects involve enzymatic biodepolymerization of waste plastics (PE, PET, laminates) to upcycled raw materials with added value.

Manchester, Gb

This was a short contract for @Imperagen, another spin-off from UMIF.Activities were centered on the identification of specific enzymes and enzyme classes for which the startup's protein engineering technology would be suited, articulating a problem statement for each enzyme and suggesting solutions/targets for improvement, developing insight into market size, and prioritizing projects into short term and longer term revenue generation.

Manchester, Gb

Manchester BioFactory has developed smart mutagenesis library design for Directed Evolution of enzymes and proteins, enabling considerable reduction in screening cost and shorter time to market. It is a spin off from the University of Manchester Innovation Factory.IBC is providing BioFactory with general business support, strategy, market insights, path to revenue, and leading the development of a business plan for the next several years.

Dottikon, Aargau, Ch

Dottikon - Your specialist for hazardous reactions and the strategic development and manufacturing partner of the world's leading chemical and pharmaceutical companies.More than Hazardous Reactions:-Exclusive Synthesis of APIs and performance chemicals -R&D, route finding and process development-Process intensification under cGMP-Multi-ton cGMP production-Quality management, FDA and Swissmedic approved-Over 100 years of experience in hazardous reactions-One-site strategy in Switzerland with more than 550 employees

Emeryville, Ca, Us

*In charge of the relationship with our US/Canada distributor Centerchem for Amyris' Neossance Squalane and Hemisqualane for the cosmetics industry. Technical sales support and training of distributor sales staff.*Due diligence and on-boarding of new distributors.*Invited speaker at several Dinner and/or Educational Hour meetings at Chapters of the Society for Cosmetic Chemists.*Responsible for growing sales into other markets like pharmaceuticals and animal health, cosmetic (functional) textiles, plastics, semi-conductors, etc.*As of July 2016, also in charge of distribution network in South-East Asia and Australia/New Zealand.

Saint Paul, Minnesota, Us

Marketing, Sales and New Business Development for the Purolite LifeTech product line:*Resins for enzyme immobilization and biocatalysis for Pharma, Food and Beverage, Renewable Fine Chemicals*Affinity chromatographic resins (synthetic polymers) for Biotechnology and Biopharmaceutical applications like antibodies, proteins, all based on Agarose (under development)*Analytical, preparative, and full manufacturing scale chromatographic resins (IEX, SEC, HIC, SPE) for peptides, oligonucleotides, proteins, small molecules*Polymers for solid phase synthesis of peptides or oligonucleotidesResponsibilities:-Distribution and Sales strategy-Conferences and Trade Shows-Tech Support

The purpose of this blog is to highlight some of the recent successes of Industrial Biocatalysis, as well as to explain some of the more intricate aspects of enzymatic catalysis. In just a few months, I had a significant readership (thousands) from 5 continents.

Redwood City, Ca, Us

As project manager, plotted scientific strategy of our cellulase enzyme development project in Singapore. Effectively collaborated across competencies (Legal, Business Development, Corporate Development, R&D, Finance) to ensure FTE resource meets contractual obligations without over-staffing, yet meeting milestones on the programs. Responsible for outsourcing a renewable chemicals project including contract negotiations (CDAs, MTAs, MSAs) with CMOs and catalyst companies.

Redwood City, Ca, Us

In charge of service projects in the field of phase 1 metabolite synthesis and isolation using Codexis' proprietary enzyme systems. Streamlined portfolio of cytochrome P450 products. Technical support of the business development team by writing protocols and technical documentation, and by giving many biocatalysis seminars across Europe, US, and in Japan. Developed content for a biocatalysis webinar (together with Merck process chemistry), developed theoretical and practical content for in-house training days at our customers to demonstrate how easy it is to use enzymes. Speaking engagements at trade shows like Informex, Society for Industrial Microbiology, the Gordon Research Conference, the ACS Green Chemistry conference.

Redwood City, Ca, Us

In this position I was General Manager of this acquired site of around 25 people. Responsible for integration of this R&D site into the main California operations and interfaced between the business development team and customers. Built a group structure that delivered on enzyme evolution programs, enzyme screens for internal and external parties whilst keeping ongoing research enzyme business flourishing. When the 2008 downturn in the economy forced Codexis to concentrate all activities back at HQ, managed the wind-down of activities (sadly including a RIF) and transfer of assets and programs to Redwood City.

Redwood City, Ca, Us

Technical Lead on two projects, one involving enzyme improvement and process development for an intermediate for Ezetimibe, and the other project was an enzyme platform development (halohydrin dehalogenase).

Small, privately owned biotech utilizing and marketing enzymatic technology of the University of Groningen. Successfully applied for start-up subsidies at local and national government institutes, co-wrote project proposals that resulted in several projects with multinationals which again resulted in two patents on enzymatic routes to statin intermediates (with DSM) and one patent application on a biocatalytic route to diltiazem that sadly was not converted (with Rhodia).Sold assets to Codexis in 2006.

Groningen, Nl

Worked on Penicillin Acylase, Epoxide Hydrolase, CoA-ligase, Haloalcohol dehalogenase (later became Enzis technology).Project coordinator for the EU EPOX project on epoxide hydrolases (industrial partner Fluka) responsible for scientific reports and dissemination of results, project meetings, etc.Project coordinator for "Cluster project antibiotics" (industrial partners DSM and Gist Brocades) responsible for interface between University and industrial partners, reports, meeting minutes, etc.

Dr, Bioorganic Chemistry

Education record